Dr. Sheikh Shehzad Parviz, MD

Dr. Parviz practices at Holy Cross Hospital in Silver Spring, Maryland, part of Trinity Health.

Dr. Parviz's NPI, 1346215621, was assigned on February 21, 2006. Dr. Parviz holds Maryland license D73158.

Dr. Parviz's primary practice is Holy Cross Hospital, at 1500 Forest Glen Road, Silver Spring, MD 20910 in Montgomery County. The practice phone is (301) 754-7000.

Dr. Parviz's primary practice is Holy Cross Hospital in Silver Spring, Maryland, part of Trinity Health. Dr. Parviz is also affiliated with Adventist HealthCare White Oak Medical Center. The medical group on file is MedStar Medical Group. Dmand AI also links Dr. Parviz to 3 more hospitals, 8 medical groups, 2 skilled nursing facilities, 1 physician office, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Parviz practices, 10 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Parviz's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dmand AI has Dr. Parviz's licenses on file in 3 states: Maryland, Pennsylvania and West Virginia.

CMS data shows 1,994 Medicare services from Dr. Parviz across 13 procedure codes in 2024, for 456 Medicare patients. Medicare paid $189,834 for them.

CMS counts 456 Medicare patients who saw Dr. Parviz in 2024. The largest group is 75 to 84, with 170 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 2.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Parviz's median patient age at 66, with 50% women.

In 2024, Dr. Parviz wrote 2,847 Medicare Part D claims for 155 patients. 91% of them were for generic drugs. CMS names the drug for 2,474 of them, across 78 drugs with 11 or more claims each, at $128,465 in total drug cost. In 2023, CMS named 3,333 claims across 87 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Parviz for performance year 2024, reported through an alternative payment model (APM). Dr. Parviz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Parviz as offering telehealth.

CMS Open Payments shows 9 general payments to Dr. Parviz from 4 drug and device companies from 2016 to 2024. Speaker and faculty fees make up the largest share, 78% of the total. Allergan Inc. paid the most, $1,630.